A search team of research in the US reveal the results of the man’s clinical experience for a new genetic genetic treatment, which affects more than 32.5 million adults in the United States only.
Researchers indicate that traditional drugs that have just got the kicking up quickly in the golden commuzion, which makes it inuits in the long run. As for the genetic therapy, turn the common cells in a permanent factory for production of anti -inflamer drugs, allowing the continuation of the event more than one year. The results have been published, Wednesday, in medicine “science translating” Journal.
The knee’s region is one of the most common types of Arthritis, and the Court of the cartilage that covers the ends, which brings to the orcity and difficulty and difficulty. This condition is one of the chronic disease that is difficult to treat.
The knee drowns a lot of life quality, as the restriction movement and causes continuous pain that prevents each day.
The new genetic therope depends on a genicine known as the il and the molic that makes a big role and erosion of the cartilage associated with the residence.
The team has developed this treatment for the first time in 2000, using a safe virus as “AAV” to transport the cedi and laboratory animals from corrosion.
Clinical experiments were retaliated for many years due to organization and industrial challenges finally puts a mechanism to speed on the project to notify the project
During the clinical study, 9 patients with knee roughness received experimental genetic therapy inside that knee. The levels found that the protruding level to il-1 protein and remain in more than one year old, and participants informed of the knee, without a realm safe effects.
According to the researchers, the results of the clinical experiments declined that the terraal genae treatment, where they had a great time, and provided the participant’s clinical benefits.
The team has adjusted that «this treatment can revolt the road to the knee roughness, like all medications is angry out in the hours, while the genetic treatment allows cells.
Researchers obsetted that the success of the first stage pavement the way to larger clinical experiences (the second and third and the third and fence) to assess the next. Hard success successful the next steps.
0 Comments